title: Bed time NPH-insulin plus combined sulfonylurea-biguanide oral therapy for treating refractory non insulin dependent diabetic patients.
authors.forename: G
authors.initials: G
authors.lastname: di Cianni
authors.forename: L
authors.initials: L
authors.lastname: Benzi
authors.forename: A M
authors.initials: AM
authors.lastname: Ciccarone
authors.forename: P
authors.initials: P
authors.lastname: Cecchetti
authors.forename: R
authors.initials: R
authors.lastname: Navalesi
mesh_terms: D001786:Blood Glucose / Q000378:metabolism; D002096:C-Peptide / Q000097:blood; D003920:Diabetes Mellitus / Q000097:blood / Q000178:diet therapy / Q000188:drug therapy*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005934:Glucagon; D005905:Glyburide / Q000008:administration & dosage / Q000627:therapeutic use*; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D007336:Insulin, Isophane / Q000008:administration & dosage / Q000627:therapeutic use*; D008875:Middle Aged; D009765:Obesity; D010629:Phenformin / Q000008:administration & dosage / Q000627:therapeutic use*; D013997:Time Factors; D015431:Weight Loss
chemical_list: D001786:Blood Glucose; D002096:C-Peptide; D005934:Glucagon; D005905:Glyburide; D006442:Glycated Hemoglobin; D007336:Insulin, Isophane; D010629:Phenformin